Contact

Click here for a confidential contact or call:

1-212-350-2764
Page 3 of 52

The Antitrust Week In Review

Posted  05/4/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

Warren, Ocasio-Cortez want to stop many company mergers during coronavirus pandemic.  Two of the most popular Democrats, Senator Elizabeth Warren and Representative Alexandria Ocasio-Cortez, said on Tuesday they would introduce legislation to stop many mergers while the United States struggles economically...

The Antitrust Week In Review

Posted  04/27/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

Key U.S. lawmaker pushes for a ban on mergers until coronavirus pandemic ends.  The chair of the House Judiciary Committee’s antitrust panel on Thursday called for a moratorium on mergers in the next coronavirus stimulus package and a ban on deals that are not directly related to companies about to fail....

The Antitrust Week In Review

Posted  04/20/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

U.S. regulators warn companies against collusion to limit essential workers' wages.  The two U.S. antitrust enforcers said that they would be keeping a sharp eye on companies to ensure that they do not seek to exploit nurses, doctors, store clerks and others working despite the coronavirus pandemic. The...

Universities May Incur Antitrust Liability Acting Jointly in Response to the COVID-19 Pandemic

Posted  04/17/20
By Ethan E. Litwin, J. Wyatt Fore
The upheaval caused by the COVID-19 pandemic has forced virtually every company and institution engaged in commercial transactions to re-evaluate and drastically alter its business practices.  While they are wise to do so, they would also be wise to remember that their susceptibility to the commercial effects of the pandemic offers no immunity from antitrust enforcement where companies have entered into...

The Antitrust Week In Review

Posted  04/13/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

Generic drugmakers win EU okay to cooperate in coronavirus fight.  Generic drugmakers will be allowed to cooperate to supply hospital medicines for COVID-19 patients without fear of breaching the bloc’s competition rules, EU antitrust regulators said on Wednesday. The step is the latest loosening of the...

The Antitrust Week In Review

Posted  04/6/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

Explainer: Antitrust law won't get in the way of U.S. acting to raise oil prices.  It is illegal for oil producers to meet to discuss pushing up oil prices under U.S. antitrust law, but perfectly legal if state regulators or the federal government set lower production levels for them, U.S. antitrust...

The Antitrust Week In Review

Posted  03/30/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

U.S. antitrust agencies pledge quick action for anti-COVID-19 efforts.  The two U.S. federal antitrust enforcers said on Tuesday that they would move quickly to approve collaborations that businesses, including hospital systems, put together to address rapidly growing public health concerns raised by the...

The Antitrust Week In Review

Posted  03/23/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

EU regulators ask companies to delay merger filings over coronavirus disruption.  European Union regulators have asked companies seeking to complete their desired mergers to delay submitting antitrust filings due to the coronavirus outbreak.  That could affect the timelines of agreed deals. Among the...

The Antitrust Week In Review

Posted  03/17/20
Here are some of the developments in antitrust news this past week that we found interesting and are following. France Fines Apple $1.2 Billion for Antitrust Issues.  France’s antitrust regulator on Monday fined Apple 1.1 billion euros, or $1.2 billion, putting more pressure on the company as it grapples with the coronavirus outbreak that has threatened its supply chains and closed its retail stores. France’s...

The Antitrust Week In Review

Posted  03/9/20
Here are some of the developments in antitrust news this past week that we found interesting and are following. Novartis unit Sandoz agrees to pay $195 million to resolve antitrust charges.  Novartis’ generic drugs unit Sandoz has agreed to pay $195 million to reach a deferred prosecution agreement aimed at resolving antitrust charges, the Justice Department said. The company was charged with rigging bids and...
1 2 3 4 5 52

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: